Founders Capital Management (Connecticut)’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.82M | Sell |
18,820
-43
| -0.2% | -$14.7K | 1.02% | 21 |
|
|
2026
Q1 | $6.64M | Hold |
18,863
| – | – | 1.09% | 21 |
|
|
2025
Q4 | $6.17M | Sell |
18,863
-143
| -0.8% | -$45.4K | 0.92% | 24 |
|
|
2025
Q3 | $5.36M | Sell |
19,006
-2
| -0% | -$580 | 0.84% | 24 |
|
|
2025
Q2 | $5.31M | Sell |
19,008
-45
| -0.2% | -$12.7K | 0.9% | 23 |
|
|
2025
Q1 | $5.94M | Sell |
19,053
-111
| -0.6% | -$32.8K | 1.09% | 23 |
|
|
2024
Q4 | $4.99M | Sell |
19,164
-870
| -4% | -$258K | 0.88% | 25 |
|
|
2024
Q3 | $6.46M | Sell |
20,034
-91
| -0.5% | -$29.8K | 1.12% | 26 |
|
|
2024
Q2 | $6.29M | Sell |
20,125
-223
| -1% | -$65.5K | 1.13% | 24 |
|
|
2024
Q1 | $5.79M | Hold |
20,348
| – | – | 1.07% | 25 |
|
|
2023
Q4 | $5.86M | Buy |
20,348
+5,000
| +33% | +$1.36M | 1.2% | 23 |
|
|
2023
Q3 | $4.12M | Hold |
15,348
| – | – | 0.94% | 25 |
|
|
2023
Q2 | $3.41M | Sell |
15,348
-302
| -2% | -$70.1K | 0.76% | 28 |
|
|
2023
Q1 | $3.78M | Hold |
15,650
| – | – | 0.94% | 24 |
|
|
2022
Q4 | $4.11M | Hold |
15,650
| – | – | 1.1% | 24 |
|
|
2022
Q3 | $3.53M | Hold |
15,650
| – | – | 0.99% | 23 |
|
|
2022
Q2 | $3.81M | Hold |
15,650
| – | – | 0.98% | 23 |
|
|
2022
Q1 | $3.78M | Hold |
15,650
| – | – | 0.81% | 25 |
|
|
2021
Q4 | $3.52M | Buy |
15,650
+299
| +2% | +$63.1K | 0.76% | 30 |
|
|
2021
Q3 | $3.26M | Buy |
15,351
+211
| +1% | +$48.6K | 0.82% | 26 |
|
|
2021
Q2 | $3.69M | Sell |
15,140
-1,972
| -12% | -$485K | 0.89% | 25 |
|
|
2021
Q1 | $4.26M | Buy |
17,112
+1,972
| +13% | +$471K | 1.07% | 23 |
|
|
2020
Q4 | $3.48M | Hold |
15,140
| – | – | 1.01% | 23 |
|
|
2020
Q3 | $3.85M | Sell |
15,140
-1
| -0% | -$248 | 1.22% | 22 |
|
|
2020
Q2 | $3.57M | Hold |
15,141
| – | – | 1.22% | 22 |
|
|
2020
Q1 | $3.07M | Buy |
15,141
+90
| +0.6% | +$19.7K | 1.22% | 24 |
|
|
2019
Q4 | $3.63M | Hold |
15,051
| – | – | 1.2% | 21 |
|
|
2019
Q3 | $2.94M | Sell |
15,051
-75
| -0.5% | -$14.4K | 1.05% | 21 |
|
|
2019
Q2 | $2.79M | Buy |
15,126
+147
| +1% | +$26.3K | 0.99% | 23 |
|
|
2019
Q1 | $2.85M | Buy |
14,979
+5,580
| +59% | +$1.07M | 1.04% | 23 |
|
|
2018
Q4 | $1.83M | Sell |
9,399
-536
| -5% | -$105K | 0.78% | 29 |
|
|
2018
Q3 | $2.05M | Hold |
9,935
| – | – | 0.84% | 27 |
|
|
2018
Q2 | $1.83M | Hold |
9,935
| – | – | 0.84% | 25 |
|
|
2018
Q1 | $1.65M | Hold |
9,935
| – | – | 0.76% | 29 |
|
|
2017
Q4 | $1.73M | Hold |
9,935
| – | – | 0.77% | 30 |
|
|
2017
Q3 | $1.85M | Sell |
9,935
-645
| -6% | -$114K | 0.88% | 30 |
|
|
2017
Q2 | $1.82M | Hold |
10,580
| – | – | 0.91% | 28 |
|
|
2017
Q1 | $1.74M | Hold |
10,580
| – | – | 0.89% | 27 |
|
|
2016
Q4 | $1.55M | Hold |
10,580
| – | – | 0.84% | 28 |
|
|
2016
Q3 | $1.76M | Hold |
10,580
| – | – | 0.99% | 27 |
|
|
2016
Q2 | $1.61M | Hold |
10,580
| – | – | 0.91% | 31 |
|
|
2016
Q1 | $1.59M | Hold |
10,580
| – | – | 0.92% | 30 |
|
|
2015
Q4 | $1.72M | Sell |
10,580
-155
| -1% | -$24.4K | 1.03% | 29 |
|
|
2015
Q3 | $1.49M | Hold |
10,735
| – | – | 0.96% | 29 |
|
|
2015
Q2 | $1.65M | Hold |
10,735
| – | – | 0.99% | 29 |
|
|
2015
Q1 | $1.72M | Hold |
10,735
| – | – | 1.03% | 27 |
|
|
2014
Q4 | $1.71M | Buy |
10,735
+300
| +3% | +$46.7K | 1.05% | 28 |
|
|
2014
Q3 | $1.47M | Hold |
10,435
| – | – | 0.94% | 30 |
|
|
2014
Q2 | $1.24M | Hold |
10,435
| – | – | 0.82% | 33 |
|
|
2014
Q1 | $1.29M | Hold |
10,435
| – | – | 1.03% | 29 |
|
|
2013
Q4 | $1.19M | Buy |
+10,435
| New | +$1.19M | 1% | 31 |
|
Other funds holding AMGN
Founders Capital Management (Connecticut)'s AMGN Position: Q2 2026 in Review
Founders Capital Management (Connecticut) reduced its Amgen (AMGN) stake by 0.23% in Q2 2026, selling an estimated $14.7K and leaving 18,820 shares worth $6.82M. The position accounts for 1.02% of the portfolio, ranked #21.
Founders Capital Management (Connecticut) first reported a position in AMGN in Q4 2013 and has held it in 51 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Founders Capital Management (Connecticut) held 18,820 shares of Amgen worth $6.82M as of Q2 2026.
- Founders Capital Management (Connecticut) sold 43 Amgen shares in Q2 2026, an estimated $14.7K.
- Amgen made up 1.02% of Founders Capital Management (Connecticut)'s portfolio in Q2 2026, its #21 holding.
- Founders Capital Management (Connecticut) first reported a position in Amgen in Q4 2013 and has held it in 51 quarters since.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Founders Capital Management (Connecticut)'s 13F filing for Q2 2026, filed 20 Jul 2026.